GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer

MT NewswiresDec 16 09:21 ET

GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK

Proactive InvestorsDec 16 03:18 ET

GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA

MT NewswiresDec 16 02:42 ET

GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission

WSJDec 16 02:37 ET

United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis

BenzingaDec 13 11:06 ET

Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing

BenzingaDec 12 13:13 ET